Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS)
CNY 17.75
(1.89%)
CNY 17.75
(1.89%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 284.15 Million CNY | 24.33% |
| 2022 | 228.55 Million CNY | 25.8% |
| 2021 | 181.67 Million CNY | 10.97% |
| 2020 | 163.71 Million CNY | 2.69% |
| 2019 | 159.43 Million CNY | 31.97% |
| 2018 | 120.8 Million CNY | 1.61% |
| 2017 | 118.88 Million CNY | -5.87% |
| 2016 | 126.3 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 91.65 Million CNY | 90.92% |
| 2024 Q2 | 49.23 Million CNY | -42.14% |
| 2024 Q1 | 85.09 Million CNY | 36.05% |
| 2023 Q3 | 81.18 Million CNY | 19.66% |
| 2023 Q1 | 72.56 Million CNY | 38.46% |
| 2023 FY | 284.15 Million CNY | 24.33% |
| 2023 Q2 | 67.85 Million CNY | -6.5% |
| 2023 Q4 | 62.54 Million CNY | -22.96% |
| 2022 Q3 | 52.84 Million CNY | 19.99% |
| 2022 FY | 228.55 Million CNY | 25.8% |
| 2022 Q4 | 52.41 Million CNY | -0.82% |
| 2022 Q2 | 44.04 Million CNY | -44.43% |
| 2022 Q1 | 79.25 Million CNY | 41.79% |
| 2021 Q4 | 55.89 Million CNY | 28.54% |
| 2021 Q3 | 43.48 Million CNY | 3.05% |
| 2021 Q1 | 40.08 Million CNY | -5.77% |
| 2021 Q2 | 42.2 Million CNY | 5.28% |
| 2021 FY | 181.67 Million CNY | 10.97% |
| 2020 Q2 | 50.18 Million CNY | 57.43% |
| 2020 FY | 163.71 Million CNY | 2.69% |
| 2020 Q4 | 42.54 Million CNY | 8.79% |
| 2020 Q3 | 39.1 Million CNY | -22.08% |
| 2020 Q1 | 31.87 Million CNY | -25.01% |
| 2019 Q3 | 42.5 Million CNY | 15.32% |
| 2019 FY | 159.43 Million CNY | 31.97% |
| 2019 Q4 | 42.5 Million CNY | 0.0% |
| 2019 Q2 | 36.86 Million CNY | 0.0% |
| 2019 Q1 | 36.86 Million CNY | 0.0% |
| 2018 FY | 120.8 Million CNY | 1.61% |
| 2017 FY | 118.88 Million CNY | -5.87% |
| 2016 FY | 126.3 Million CNY | 0.0% |